The authors reply

Affiliations

¹ Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands. Electronic address: Anne-Els.vandelogt@radboudumc.nl.
² AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, Paris, France.
³ AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, Paris, France; Institut National de la Santé et de la Recherche Médicale UMR_S1155, Paris, France.
⁴ Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

Free article

Comment

Anne-Els van de Logt et al. Kidney Int. 2018 Oct.

Free article

. 2018 Oct;94(4):830.

doi: 10.1016/j.kint.2018.06.018.

¹ Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands. Electronic address: Anne-Els.vandelogt@radboudumc.nl.
² AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, Paris, France.
³ AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, Paris, France; Institut National de la Santé et de la Recherche Médicale UMR_S1155, Paris, France.
⁴ Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

No abstract available

Comment on

Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
van de Logt AE, Dahan K, Rousseau A, van der Molen R, Debiec H, Ronco P, Wetzels J. van de Logt AE, et al. Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019. Kidney Int. 2018. PMID: 29571438 No abstract available.
Antibodies to M-type phospholipase receptor and immunological remission in treatment-resistant and relapsing membranous nephropathy.
Ramachandran R, Yadav AK, Sethi J, Gupta KL, Jha V. Ramachandran R, et al. Kidney Int. 2018 Oct;94(4):829-830. doi: 10.1016/j.kint.2018.06.017. Kidney Int. 2018. PMID: 30243320 No abstract available.